RPG Life Sciences Limited (RPGLIFE.BO)

INR 2064.1

(4.69%)

Market Cap (In INR)

34.13 Billion

Revenue (In INR)

5.82 Billion

Net Income (In INR)

876.6 Million

Avg. Volume

1425.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1290.3-2976.7
PE
43.08
EPS
47.91
Beta Value
0.433
ISIN
INE105J01010
CUSIP
-
CIK
-
Shares
16537798.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yugal Kishor Choturam Sikri
Employee Count
-
Website
https://www.rpglifesciences.com
Ipo Date
Details
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies. It operates in nephrology, rheumatology, oncology, gastroenterology, cardiovascular, orthopedics, respiratory, neurology, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology, pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.